CompoAtlas

HydroxyStim

HydroxyStim, licence 80039030: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Xenadrine Core
Licence holder
Iovate Health Sciences International Inc.
NPN or DIN-HM
80039030
Status
Active licence
Licence date
28 January 2013
Revision date
15 December 2016
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
2-hydroxy-N,N,N-triméthyléthanaminium

Source : Bitartrate de choline

10.0 milligrammeNot calculated
Plectranthus barbatus

Source : Racine

Potency : 10.0 Pour cent Colforsin

Not specifiedNot calculated
Plectranthus barbatus

Source : Racine

Extraction ratio : 50.0:1.0

Dry plant equivalent : 4.165 g

Not specifiedNot calculated
Plectranthus barbatus

Source : Racine

83.3 milligrammeNot calculated
1,3,7-triméthylxanthine

Source : Caféine

100.0 milligrammeNot calculated
Centella asiatica

Source : Plante

Extraction ratio : 4.0:1.0

Dry plant equivalent : 100.0 mg

Not specifiedNot calculated
Centella asiatica

Source : Centella asiatica

Extraction ratio : 4.0:1.0

Dry plant equivalent : 100.0 mg

Not specifiedNot calculated
Centella asiatica

Source : Plante

25.0 milligrammeNot calculated
Centella asiatica

Source : Centella asiatica

25.0 milligrammeNot calculated
[5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one

Source : Plante entière

13.0 microgrammesNot calculated
[5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one

Source : Huperzine A

13.0 microgrammesNot calculated

Non-medicinal ingredients

Bleu brilliant FCF, Cellulose microcristalline, Pigments nacrés à base de mica, Talc, Stéarate de magnésium, Gélatine, Rouge allura AC, Silice

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18.0 Année(s) ; maximum: 37.0 Année(s)3.0 Capsule1.0 Jour(s)

Uses authorised in Canada

Helps to relieve fatigue, promote endurance and enhance motor performance. Helps to promote alertness and wakefulness.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80039030

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2016. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line